Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis

American Heart Journal

Volumn 134, Issue 1, 1997, Pages 69-72

  Mikkola, K M ^a   Patel, S R ^a   Parker, J A ^a   Grodstein, F ^a   Goldhaber, S Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; AGING; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BODY MASS; CATHETERIZATION; DATA BASE; HEMATOCRIT; HEMATURIA; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OCCULT BLOOD; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030792024     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70108-X     Document Type: Article

References (14)

1. SZ Goldhaber DE Vaughan JE Markis AP Selwyn MF Meyerovitz J Loscalzo DS Kim CM Kessler DL Dawley GVRK Sharma A Sasahara EB Grossbard E Braunwald Acute pulmonary embolism treated with tissue plasminogen activator Lancet 2 1986 886 889
2. SZ Goldhaber MF Meyerovitz JE Markis D Kim CM Kessler GVRK Sharma DE Vaughan AP Selwyn DL Dawley J Loscalzo AA Sasahara EB Grossbard E Braunwald Thrombolytic therapy of acute pulmonary embolism: current status and future potential J Am Coll Cardiol 10 1987 96B 104B
3. SZ Goldhaber JE Markis CM Kessler MF Meyerovitz D Kim DE Vaughan AP Selwyn J Loscalzo DL Dawley GVRK Sharma A Sasahara EB Grossbard E Braunwald Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator Semin Thromb Haemost 13 1987 171 177
4. SZ Goldhaber CM Kessler J Heit J Markis GVRK Sharma D Dawley JS Nagel M Meyerovitz D Kim DE Vaughan JA Parker SS Tumeh D Drum J Loscalzo K Reagan AP Selwyn J Anderson E Braunwald Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism Lancet 2 1988 293 298
5. SZ Goldhaber CM Kessler JA Heit CG Elliott WR Friedenberg DE Heiselman DB Wilson JA Parker D Bennett ML Feldstein AP Selwyn D Kim GVRK Sharma JS Nagel MF Meyerovitz Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial J Am Coll Cardiol 20 1992 24 30
6. SZ Goldhaber WD Haire ML Feldstein M Miller R Toltzis JL Smith AM Taveira Da Silva PC Come RT Lee JA Parker A Mogtader TJ McDonough E Braunwald Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion Lancet 341 1993 507 511
7. SZ Goldhaber G Agnelli MN Levine on behalf of the Bolus Alteplase Pulmonary Embolism Group Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis Chest 106 1994 718 724
8. CR Mehta NR Patel A network algorithm for performing Fisher’s exact test in rXc contingency tables J Am Stat Assoc 78 1983 427 434
9. BR Chaitman B Thompson MD Wittry D Stump WP Hamilton LD Hills JG Dwyer RE Solomon GL Knatterud for the TIMI Investigators The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction phase I, open label studies and the thrombolysis in myocardial infarction phase II pilot study J Am Coll Cardiol 14 1989 1159 1165
10. N Meneveau JP Bassand F Schiele Y Bouras T Anguenot Y Bernard R Schultz Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients J Am Coll Cardiol 22 1993 1075 1079
11. M Gisselbrecht JL Diehl G Meyer MA Collignon H Sors Clinical presentation and results of thrombolytic therapy in older patients with massive pulmonary embolism: a comparison with nonelderly patients J Am Geriatr Soc 44 1996 189 193
12. The Urokinase Pulmonary Embolism Trial: a national cooperative study Circulation 47 suppl 2 1973 I108
13. Urokinase-Streptokinase Embolism Trial: phase 2 results JAMA 229 1974 1606 1613
14. M Levine J Hirsh J Weitz M Cruickshank J Neemeh AG Turpie M Gent A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism Chest 98 1990 1473 1479